LIPOCINE INC. Total Liabilities and Equity
LIPOCINE INC. (LPCN) had Total Liabilities and Equity of $23.84 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-04
- 2026-06-30: Liabilities and Equity $23.84M.
- 2026-03-31: Liabilities and Equity $25.36M.
- 2025-12-31: Liabilities and Equity $17.01M.
- 2025-09-30: Liabilities and Equity $16.07M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $23.84M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $25.36M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $17.01M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $16.07M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $18.58M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $20.50M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $22.51M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $20.70M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $23.03M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $25.45M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $23.00M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $24.75M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $30.48M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $34.02M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $37.54M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $39.42M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $42.19M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $47.60M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $52.48M 10-K · filed 2023-03-10 | |
| 2021-09-30 | $40.39M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $47.18M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $50.58M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $25.35M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $24.75M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $23.49M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $20.99M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $19.66M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $17.34M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $19.68M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $22.99M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $20.85M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $22.69M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $25.30M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $31.68M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $25.33M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $26.26M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $28.05M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $27.22M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $27.34M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $29.55M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $33.35M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $38.77M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $45.38M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $48.43M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $53.80M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $25.06M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $27.99M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $32.02M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $35.49M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $42.10M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $46.11M 10-K · filed 2015-03-11 | |
| 2013-09-30 | $37.17M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $10.00 10-Q · filed 2013-07-09 | |
| 2013-03-31 | $458.00 10-Q · filed 2013-04-24 | |
| 2012-12-31 | $5.57M 10-K · filed 2014-03-31 | $577.00 10-K · filed 2013-02-26 |
| 2012-09-30 | $622.00 10-Q · filed 2012-10-26 | |
| 2011-12-31 | $32.44K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |